Why the study?
What are the clinical implications of variable response to clopidogrel therapy in patients with coronary artery disease?
Population
Patients with coronary artery disease receiving clopidogrel therapy
Design
Review
Authors
Loading...
Clopidogrel hyporesponse may elevate thrombotic risk in CAD; leaves open whether testing-guided adjustments improve outcomes.
What are the clinical implications of variable response to clopidogrel therapy in patients with coronary artery disease?
Despite inter-individual variability in clopidogrel response being linked to thrombotic events, routine platelet function testing and higher maintenance doses are not currently recommended by guidelines.
Miguel et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: